Twist Bioscience launches gene fragments for clone screening

 

• Twist Bioscience (TWST +5.1%) has launched Clonal-Ready Gene Fragments, with and without adapters, can be used to build constructs and minimize the time and cost of screening for perfect clones.
• The Fragments begin as oligonucleotides synthesized on Twist Bioscience’s semiconductor-based silicon platform. The oligonucleotides are then annealed together and PCR-amplified to produce a double-stranded DNA fragment and error-corrected through an enzymatic reaction. The resulting product is a ready-to-use Gene Fragment that is compatible with many applications including cloning, gene and protein expression, pathway and enzyme engineering and enzyme optimization.
• https://seekingalpha.com/news/3643426-twist-bioscience-launches-gene-fragments-for-clone-screening